According to Genetic Signatures latest financial reports the cash on hand of GSS is $10.19M, an decrease of -55.69% to 2022. At the end of 2022 company had $22.99M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $10.19M | -55.69% |
2022 | $22.99M | 22.50% |
2021 | $18.77M | -3.38% |
2020 | $19.43M | 393.95% |
2019 | $3.93M | - |